141 related articles for article (PubMed ID: 12702145)
21. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma.
Buchner A; Riesenberg R; Kotter I; Crispin A; Hofstetter A; Oberneder R
J Urol; 2003 Nov; 170(5):1747-51. PubMed ID: 14532768
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy.
Braun S; Cevatli BS; Assemi C; Janni W; Kentenich CR; Schindlbeck C; Rjosk D; Hepp F
J Clin Oncol; 2001 Mar; 19(5):1468-75. PubMed ID: 11230493
[TBL] [Abstract][Full Text] [Related]
23. Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance.
Choesmel V; Pierga JY; Nos C; Vincent-Salomon A; Sigal-Zafrani B; Thiery JP; Blin N
Breast Cancer Res; 2004; 6(5):R556-70. PubMed ID: 15318937
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
Diel IJ; Cote RJ
Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
[TBL] [Abstract][Full Text] [Related]
25. Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice.
Van Muijen GN; Cornelissen LM; Jansen CF; Figdor CG; Johnson JP; Bröcker EB; Ruiter DJ
Clin Exp Metastasis; 1991; 9(3):259-72. PubMed ID: 2060184
[TBL] [Abstract][Full Text] [Related]
26. Immunocytochemical detection of tumor cells in bone marrow and peripheral blood stem cell collections from patients with ovarian cancer.
Ross AA; Miller GW; Moss TJ; Kahn DG; Warner NE; Sweet DL; Louie KG; Schneidermann E; Pecora AL; Meagher RC
Bone Marrow Transplant; 1995 Jun; 15(6):929-33. PubMed ID: 7581093
[TBL] [Abstract][Full Text] [Related]
27. Micrometastases in bone marrow: prognostic indicators for pancreatic cancer.
Roder JD; Thorban S; Pantel K; Siewert JR
World J Surg; 1999 Sep; 23(9):888-91. PubMed ID: 10449815
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of bone marrow micrometastases in patients with gastric cancer.
Jauch KW; Heiss MM; Gruetzner U; Funke I; Pantel K; Babic R; Eissner HJ; Riethmueller G; Schildberg FW
J Clin Oncol; 1996 Jun; 14(6):1810-7. PubMed ID: 8656249
[TBL] [Abstract][Full Text] [Related]
29. Specificity of tyrosinase and HMB45 PCR in the detection of melanoma metastases in sentinel lymph node biopsies.
Gutzmer R; Kaspari M; Brodersen JP; Mommert S; Völker B; Kapp A; Werfel T; Kiehl P
Histopathology; 2002 Dec; 41(6):510-8. PubMed ID: 12460203
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow-disseminated tumor cells in patients with carcinoma of the esophagus or cardia.
Bonavina L; Soligo D; Quirici N; Bossolasco P; Cesana B; Lembertenghi Deliliers G; Peracchia A
Surgery; 2001 Jan; 129(1):15-22. PubMed ID: 11150029
[TBL] [Abstract][Full Text] [Related]
31. Immunocytological detection of isolated tumour cells in the bone marrow of malignant melanoma patients: a new method for the detection of minimal residual disease.
Thybusch-Bernhardt A; Klomp HJ; Maas T; Kremer B; Juhl H
Eur J Surg Oncol; 1999 Oct; 25(5):498-502. PubMed ID: 10527598
[TBL] [Abstract][Full Text] [Related]
32. Immunocytochemical detection of neuroblastoma cells infiltrating clinical bone marrow samples.
Beck D; Maritaz O; Gross N; Favrot M; Vultier N; Bailly C; Villa I; Gentilhomme O; Philip T
Eur J Pediatr; 1988 Aug; 147(6):609-12. PubMed ID: 3053190
[TBL] [Abstract][Full Text] [Related]
33. Detection of melanoma cells displaying multiple genomic changes in histopathologically negative sentinel lymph nodes.
Ulmer A; Fischer JR; Schanz S; Sotlar K; Breuninger H; Dietz K; Fierlbeck G; Klein CA
Clin Cancer Res; 2005 Aug; 11(15):5425-32. PubMed ID: 16061857
[TBL] [Abstract][Full Text] [Related]
34. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness.
Blaheta HJ; Paul T; Sotlar K; Maczey E; Schittek B; Paul A; Moehrle M; Breuninger H; Bueltmann B; Rassner G; Garbe C
Br J Dermatol; 2001 Aug; 145(2):195-202. PubMed ID: 11531779
[TBL] [Abstract][Full Text] [Related]
35. Malignant melanoma metastatic to bone marrow.
Basu D; Bhade BA; Ghotekar LH; Mathew T; Dutta TK
Indian J Pathol Microbiol; 2002 Jan; 45(1):107-9. PubMed ID: 12593576
[TBL] [Abstract][Full Text] [Related]
36. Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer.
Ohgami A; Mitsudomi T; Sugio K; Tsuda T; Oyama T; Nishida K; Osaki T; Yasumoto K
Ann Thorac Surg; 1997 Aug; 64(2):363-7. PubMed ID: 9262576
[TBL] [Abstract][Full Text] [Related]
37. Tumor angiogenesis and micrometastasis in bone marrow of patients with early gastric cancer.
Maehara Y; Hasuda S; Abe T; Oki E; Kakeji Y; Ohno S; Sugimachi K
Clin Cancer Res; 1998 Sep; 4(9):2129-34. PubMed ID: 9748130
[TBL] [Abstract][Full Text] [Related]
38. Immunomagnetic detection of micrometastatic cells in bone marrow of uveal melanoma patients: a paradox.
Eide N; Faye RS; Høifødt HK; Sandstad B; Qvale G; Faber R; Jebsen P; Kvalheim G; Fodstad Ø
Acta Ophthalmol; 2015 Feb; 93(1):59-66. PubMed ID: 25613126
[TBL] [Abstract][Full Text] [Related]
39. Hematogenous micrometastases in osteosarcoma patients.
Bruland OS; Høifødt H; Saeter G; Smeland S; Fodstad O
Clin Cancer Res; 2005 Jul; 11(13):4666-73. PubMed ID: 16000559
[TBL] [Abstract][Full Text] [Related]
40. Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer.
Solomayer EF; Diel IJ; Wallwiener D; Bode S; Meyberg G; Sillem M; Gollan C; Kramer MD; Krainick U; Bastert G
Br J Cancer; 1997; 76(6):812-8. PubMed ID: 9310251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
